Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$107.07 USD

107.07
2,315,584

+4.49 (4.38%)

Updated Aug 14, 2024 01:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 21% (197 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Maharathi Basu headshot

5 Stocks Favored by Brokers Amid the Current Turbulence

We believe that stocks like CVR Energy (CVI), Delek US Holdings (DK), Bread Financial (BFH), Dish Network (DISH) and Cardinal Health (CAH) should be on an investor's watchlist.

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cardinal (CAH) Down 2.7% Since Last Earnings Report: Can It Rebound?

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cardinal Health's (CAH) Latest Launch to Enhance Neonatal Feeding

Cardinal Health's (CAH) latest offering is likely to help premature and newborn infants develop the oral coordination skills important for the faster transition to independent feeding.

AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment

The FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely to remove thrombus and embolic material and minimize blood loss via blood recirculation.

Patterson Companies (PDCO) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Patterson Companies' (PDCO) broad product line.

West Pharmaceutical (WST) Hits 52-Week High: More Room to Grow?

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Cardinal Health (CAH) Q4 Earnings and Revenues Beat Estimates

Cardinal (CAH) delivered earnings and revenue surprises of 4.73% and 2%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View

Cardinal Health's (CAH) fiscal fourth-quarter results benefit from the Pharmaceutical segment's solid performance.

Shaun Pruitt headshot

Time to Buy These Medical Stocks as Earnings Approach

Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.

Ethan Feller headshot

Prescribing Profits: 3 Stocks to Ride the Healthcare Relative Strength

Over the last month, Healthcare has been the second strongest sector in the market

3 Reasons to Retain DaVita (DVA) Stock to Your Portfolio

DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.

Reasons to Add Patterson Companies (PDCO) to Your Portfolio Now

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Deere (DE) to Report Q3 Earnings: What's in the Offing?

Deere's (DE) third-quarter fiscal 2023 results are likely to reflect favorable farm fundamentals, partially offset by inflated costs and supply-chain headwinds.

Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of -12.50% and 3.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Cardinal Health (CAH)

Cardinal Health (CAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Beat Likely for Cardinal Health (CAH) in Q4 Earnings?

Cardinal Health's (CAH) fiscal fourth-quarter 2023 results are expected to reflect solid performance in the Pharmaceutical segment.

Henry Schein (HSIC) Surpasses Q2 Earnings Estimates

Henry Schein (HSIC) delivered earnings and revenue surprises of 4.80% and 0.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

3 MedTech Stocks Likely to Top Estimates This Earnings Season

MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EYE, CAH and HSIC are poised ahead of their earnings releases.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.